Sign in

NCT05743153Completed

Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis

OPTIMIZE-UC: Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis: A Prospective Pilot Study

Source: ClinicalTrials.gov · Last updated 22 Sept 2026

Brief summary (registry, in English)

This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active disease as well as in patients in remission. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
20 Jan 2023
Start date
1 Mar 2024
Primary completion date
1 Mar 2025
Lead sponsor
Radboud University Medical Center
NCT number
NCT05743153

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 1 Mar 2024 to the primary completion date, 1 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis;
  • Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder);
  • History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
  • History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;

Other

  • If female, the subject is pregnant or lactating (\< 1 year) or intending to become pregnant;
  • Immobilized patients who are not able to complete exercise intervention;
  • Illiteracy (disability to read and understand Dutch).

Who the study is looking for

  • Age ≥ 18 years old;
  • Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria;
  • Ability of subject to participate fully in all aspects of this project;
  • Written informed consent must be obtained and documented.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dorien Oomkens
Coordinator of this site? Confirm its status
NijmegenNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.